Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Gwolf who wrote (417)	6/12/1998 5:03:00 PM
From: Prospector	Respond to of 5402

The information is here just can't line it up did the best I could.. Prospector OXYGEN THERAPY COMPANIES Name of Company Raw Material Availability Required Mfg. Product st Production Source Facillity Capital Trade Name Cost 2 EQIV Dose Sanguine Corp Perflurocarbon Readily Avail Modest PHER 02 $ 15 - $30 Chemicals Investment Baxter Int'l Inc. Outdated In short Substantial HemAssist $100 - $150 Human Blood Supply Investment Northfield Lab Inc Outdated In Short Substantial Polyheme $100 - $150 Human Blood Supply Investment Somatogen Inc Synthesised Unlimited Very Optro $100 - $150 Homoglobin but expensive Substantial RNA to process Investment Biopure Corp Bovine Availble but Substantial Hempure $100 - $150 Blood Expensive Investment Alliance Pharm Corp Perfluocarbon Readily Avail Modest Oxygent $40 - $50 Chemicals Investment Hemsol Inc Outdated In Short Substantial Hemolink $110 - $150 Human Blood Supply Investment